APA aipamena

Kou, F., Gong, J., Li, Y., Li, J., Zhang, X., Li, J., & Shen, L. (2021). Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites. J Int Med Res.

Chicago Style aipamena

Kou, Furong, Jifang Gong, Yan Li, Jian Li, Xiaotian Zhang, Jie Li, and Lin Shen. "Phase I Study of Intraperitoneal Bevacizumab for Treating Refractory Malignant Ascites." J Int Med Res 2021.

MLA aipamena

Kou, Furong, et al. "Phase I Study of Intraperitoneal Bevacizumab for Treating Refractory Malignant Ascites." J Int Med Res 2021.